Acura Pharmaceuticals, Inc. (ACUR)

Acura Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	0	0	0.07	0.41	0.86	0.09
Cash & Cash Equivalents	0	0	0.07	0.41	0.86	0.09
Cash Growth	-	-	-84.26%	-52.09%	847.25%	-95.90%
Receivables	0	0	0.16	0.63	0.19	0.2
Other Current Assets	0	0	0.15	0.14	0.12	0.17
Total Current Assets	0	0	0.37	1.18	1.18	0.46
Property, Plant & Equipment	0	0	0.44	0.48	0.54	0.61
Intangible Assets	0	0	0	0.07	0.81	1.02
Other Long-Term Assets	0	0	-0.39	0	0.03	0.07
Total Long-Term Assets	0	0	0.49	0.56	1.38	1.69
Total Assets	0	0	0.86	1.74	2.56	2.15
Accounts Payable	0	0	0.19	0.03	0.24	0.61
Deferred Revenue	0	0	-0.23	1.31	0	0
Current Debt	0	0	0.03	6.16	0	0
Other Current Liabilities	0	0	0.52	0.02	0.84	0.83
Total Current Liabilities	0	0	0.52	7.52	1.07	1.44
Long-Term Debt	0	0	0.15	0.11	6	4.22
Other Long-Term Liabilities	0	0	0.02	0	0.23	0.11
Total Long-Term Liabilities	0	0	0.17	0.11	6.23	4.33
Total Liabilities	0	0	0.68	7.63	7.3	5.77
Total Debt	0	0	0.15	6.27	6	4.22
Debt Growth	-	-	-97.61%	4.48%	42.05%	56.79%
Common Stock	0	0	0.65	0.22	0.21	0.21
Retained Earnings	0	0	-390.08	-389.2	-388	-384.22
Comprehensive Income	0	0	0	0	0	-1.94
Shareholders' Equity	0	0	0.18	-5.89	-4.74	-3.62
Total Liabilities and Equity	0	0	0.86	1.74	2.56	2.15
Net Cash / Debt	0	0	-0.09	-5.86	-5.14	-4.13
Net Cash Per Share	-	-	-0.00	-0.18	-0.19	-0.20
Working Capital	0	0	-0.14	-6.34	0.1	-0.97
Book Value Per Share	-	-	0.00	-0.18	-0.18	-0.17

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.